Ani Pharmaceuticals (ANIP) Notes Payables (2010 - 2011)
Ani Pharmaceuticals' (ANIP) quarterly Notes Payables came in at $1.2 million in Q3 2011, up 3.92% quarter-over-quarter from $1.2 million in Q2 2011.
Analysis
Ani Pharmaceuticals (ANIP) Notes Payables (2010 - 2011) Analysis & Trends
Ani Pharmaceuticals has disclosed Notes Payables across 2 years of filings, most recently posting $1.2 million for Q3 2011.
- In Q3 2011, Notes Payables changed N/A year-over-year to $1.2 million; the TTM figure through Sep 2011 stood at $1.2 million (changed N/A YoY), while the FY2010 annual figure was $1.1 million, changed N/A from the prior year.
- Notes Payables came in at $1.2 million for Q3 2011 at Ani Pharmaceuticals, up from $1.2 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $1.2 million in Q3 2011 to a low of $1.1 million in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2011 | 1.23 Mn |
| Jun 30, 2011 | 1.19 Mn |
| Dec 31, 2010 | 1.11 Mn |